Benitec Biopharma (BNTC) Current Assets (2019 - 2025)
Benitec Biopharma (BNTC) posted Current Assets of $189.6 million for Q4 2025, up 99.41% sequentially from $95.1 million in Q3 2025, and up 140.87% YoY from $78.7 million in Q4 2024.
Benitec Biopharma (BNTC) Current Assets (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Current Assets for 7 years, with the latest figure at $189.6 million in Q4 2025.
- Quarterly Current Assets rose 140.87% year-over-year to $189.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $189.6 million (up 140.87% YoY) and the FY2025 annual result came in at $98.5 million, up 90.65% from the prior year.
- Current Assets advanced to $189.6 million in Q4 2025 per BNTC's latest filing, from $95.1 million in the prior quarter.
- Over five years, Current Assets peaked at $189.6 million in Q4 2025 and troughed at $3.7 million in Q2 2023.
- A 5-year average of $43.1 million and a median of $18.8 million in 2021 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2024: Current Assets plunged 76.61% in 2022, then surged 1285.73% in 2024.
- Over 5 years, Current Assets stood at $12.7 million in 2021, then slipped by 13.39% to $11.0 million in 2022, then jumped by 89.49% to $20.8 million in 2023, then soared by 278.5% to $78.7 million in 2024, then jumped by 140.87% to $189.6 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $189.6 million, $95.1 million, and $98.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 189.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 189.60 Mn |
| Sep 30, 2025 | 95.08 Mn |
| Jun 30, 2025 | 98.52 Mn |
| Mar 31, 2025 | 104.01 Mn |
| Dec 31, 2024 | 78.71 Mn |
| Sep 30, 2024 | 68.34 Mn |
| Jun 30, 2024 | 51.67 Mn |
| Mar 31, 2024 | 14.37 Mn |
| Dec 31, 2023 | 20.80 Mn |
| Sep 30, 2023 | 26.41 Mn |
| Jun 30, 2023 | 3.73 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 10.98 Mn |
| Sep 30, 2022 | 17.08 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Mar 31, 2022 | 8.84 Mn |
| Dec 31, 2021 | 12.67 Mn |
| Sep 30, 2021 | 16.37 Mn |
| Jun 30, 2021 | 20.61 Mn |
| Mar 31, 2021 | 12.41 Mn |